Yunshao Xu

Yunshao Xu

Auto-generated profile, based on publicly available information

Yunshao Xu

School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2023 in Journal of Medical Virology
Verified
Journal Article
Open access
QWQing Wang
Qing Wang
MJMengmeng Jia
Mengmeng Jia
MJMingyue Jiang
Mingyue Jiang
YCYanlin Cao
Yanlin Cao
PDPeixi Dai
Peixi Dai
LFLuzhao Feng
Luzhao Feng
To the best of our knowledge, no previous study has quantitatively estimated the dynamics and cumulative susceptibility to influenza infections after the widespread lifting of COVID‐19 public health measures.We constructed an imitated stochastic susceptible‐infected‐removed model using particle‐filtered Markov Chain Monte Carlo sampling to estimate the time‐dependent reproduction number of influenza based on influenza surveillance data in southern China, northern China, and the United States during the 2022–2023 season. We compared these estimates to those from 2011 to 2019 seasons without strong social distancing interventions to determine cumulative susceptibility during COVID‐19 restrictions.Compared to the 2011–2019 seasons without a strong intervention with social measures, the 2022–2023 influenza season length was 45.0%, 47.1%, and 57.1% shorter in southern China, northern China, and the United States, respectively, corresponding to an 140.1%, 74.8%, and 50.9% increase in scale of influenza infections, and a 60.3%, 72.9%, and 45.1% increase in population susceptibility to influenza.Large and high‐intensity influenza epidemics occurred in China and the United States in 2022–2023. Population susceptibility increased in 2019–2022, especially in China. We recommend promoting influenza vaccination, taking personal prevention actions on at‐risk populations, and monitoring changes in the dynamic levels of influenza and other respiratory infections to prevent potential outbreaks in the coming influenza season.

9 October 2024 in Interactive Journal of Medical Research
Verified
Journal Article
Open access
MJMingyue Jiang
Mingyue Jiang
MJMengmeng Jia
Mengmeng Jia
QWQing Wang
Qing Wang
YSYanxia Sun
Yanxia Sun
YXYunshao Xu
Yunshao Xu
LFLuzhao Feng
Luzhao Feng
Background: There has been a global decrease in seasonal influenza activity since the onset of the COVID-19 pandemic. Objective: We aimed to describe influenza activity during the 2021/2022 season and compare it to the trends from 2012 to 2023. We also explored the influence of social and public health prevention measures during the COVID-19 pandemic on influenza activity. Methods: We obtained influenza data from January 1, 2012, to February 5, 2023, from publicly available platforms for China, the United States, and Australia. Mitigation measures were evaluated per the stringency index, a composite index with 9 measures. A general additive model was used to assess the stringency index and the influenza positivity rate correlation, and the deviance explained was calculated. Results: We used over 200,000 influenza surveillance data. Influenza activity remained low in the United States and Australia during the 2021/2022 season. However, it increased in the United States with a positive rate of 26.2% in the 49th week of 2022. During the 2021/2022 season, influenza activity significantly increased compared with the previous year in southern and northern China, with peak positivity rates of 28.1% and 35.1% in the second week of 2022, respectively. After the COVID-19 pandemic, the dominant influenza virus genotype in China was type B/Victoria, during the 2021/2022 season, and accounted for >98% (24,541/24,908 in the South and 20,543/20,634 in the North) of all cases. Influenza virus type B/Yamagata was not detected in all these areas after the COVID-19 pandemic. Several measures individually significantly influence local influenza activity, except for influenza type B in Australia. When combined with all the measures, the deviance explained values for influenza A and B were 87.4% (P<.05 for measures of close public transport and restrictions on international travel) and 77.6% in southern China and 83.4% (P<.05 for measures of school closing and close public transport) and 81.4% in northern China, respectively. In the United States, the association was relatively stronger, with deviance-explained values of 98.6% for influenza A and 99.1% (P<.05 for measures of restrictions on international travel and public information campaign) for influenza B. There were no discernible effects on influenza B activity in Australia between 2020 and 2022 due to the incredibly low positive rate of influenza B. Additionally, the deviance explained values were 95.8% (P<.05 for measures of restrictions on gathering size and restrictions on international travel) for influenza A and 72.7% for influenza B. Conclusions: Influenza activity has increased gradually since 2021. Mitigation measures for COVID-19 showed correlations with influenza activity, mainly driven by the early stage of the pandemic. During late 2021 and 2022, the influence of mitigation management for COVID-19 seemingly decreased gradually, as the activity of influenza increased compared to the 2020/2021 season.

13 September 2025 in Intelligent Medicine
Verified
Journal Article
Open access
RSRui Shen
Rui Shen
XXXueying Xu
Xueying Xu
YLYugang Li
Yugang Li
YSYanxia Sun
Yanxia Sun
YXYunshao Xu
Yunshao Xu
LFLuzhao Feng
Luzhao Feng

1 September 2024 in Infectious Disease Modelling
Verified
Journal Article
Open access
QHQiangru Huang
Qiangru Huang
YSYanxia Sun
Yanxia Sun
MJMengmeng Jia
Mengmeng Jia
MJMingyue Jiang
Mingyue Jiang
YXYunshao Xu
Yunshao Xu
Weizhong YangWeizhong Yang
Weizhong Yang
The ongoing transmission of mpox in specific countries and regions necessitates urgent action. It is essential to implement targeted containment strategies that concentrate on high-risk populations and critical locations, such as college campuses, to effectively curb the spread of mpox. This study is dedicated to evaluating the performance of various vaccination and quarantine strategies in curbing the spread of mpox and estimating the outbreak risk. To accomplish this, we constructed a stochastic, agent-based, discrete-time susceptible-latent-infectious-recovered (SLIR) model, to examine mpox transmission on a simulated college campus. Our findings reveal that relying solely on PEP is insufficient in containing mpox effectively. To bolster the population immunity and protect the vulnerable, pre-exposure vaccination among high-risk populations prior to an outbreak is imperative. Our study demonstrates that a pre-exposure vaccination rate of 50% in high-risk populations can led to a remarkable 74.2% reduction of infections. This translated to a mere 1.0% cumulative infection incidence in the overall population. In cases where the desired vaccination coverage is not attainable, enhancing case detection and isolation measures can serve as an effective emergency response to contain mpox outbreaks. For pre-exposure vaccination coverage of 20% or lower, a 40% isolation ratio is necessary to keep the cumulative number of infections in check. However, when the coverage exceeds 30%, a reduced isolation ratio of 20% becomes sufficient to manage the outbreak effectively. These insights underscore the importance of strategic pre-exposure vaccination in conjunction with robust surveillance and isolation protocols to safeguard public health and prevent the escalation of mpox outbreaks.

9 October 2024 in Public Health
Verified
Journal Article
Open access
MJMengmeng Jia
Mengmeng Jia
TLTingting Li
Tingting Li
MJMingyue Jiang
Mingyue Jiang
PDPeixi Dai
Peixi Dai
WTWenge Tang
Wenge Tang
Weizhong YangWeizhong Yang
Weizhong Yang
Understanding the burden of influenza-associated acute respiratory infection (ARI) and severe ARI (SARI) is crucial for public health decision-making. A population-based study with multiple data sources was conducted to estimate the burden of influenza-associated ARI in Wanzhou District, Chongqing, southern China. Population-based surveillance study. Active surveillance of ARI was conducted in different levels of health facilities in the Wanzhou District between October 2021 and March 2022. Nasal or throat swabs were collected and tested for influenza viruses in hospital-based surveillance. A health utilisation survey was used to estimate health-seeking behaviour, and all electronic medical records were collected. An epidemiological model was used to estimate the disease burden. There were an estimated 52,960 influenza-associated ARI (95 % confidence interval [CI]: 39,213-84,891), including 2,529 SARI cases (95 % CI: 1,385-21,712) during winter 2021/22 in the Wanzhou District. The incidence rate for all influenza-associated ARI and SARI was 3,385/100,000 and 162/100,000, respectively. A higher incidence rate of influenza-associated ARI was observed among individuals aged <50 years, while a higher influenza-associated SARI rate was observed in those aged ≥50 years. Using an epidemiological model with data from multiple sources, this study documented a substantial burden of influenza-associated ARI in the Wanzhou District, highlighting the need for influenza vaccination and providing a possible foundation for public health decision-making.

15 July 2025 in Biosafety and Health
Verified
Journal Article
Open access
YXYunshao Xu
Yunshao Xu
YDYuping Duan
Yuping Duan
JYJule Yang
Jule Yang
MJMingyue Jiang
Mingyue Jiang
YSYanxia Sun
Yanxia Sun
LFLuzhao Feng
Luzhao Feng
• Scientific questions: Progression of acute respiratory infection (ARI) to a severe lower respiratory tract infection, such as pneumonia, can increase clinical severity and place a greater burden on healthcare resources. Currently, limited evidence exists on the use of machine learning to identify key pneumonia predictors from a broad range of potential factors, including demographic, clinical, and pathogen detection data. • Evidence before this study: Certain respiratory pathogens and clinical indicators have been identified as potential risk factors for pneumonia. However, the strength of the association between each indicator and pneumonia development remains unclear, and there is a need to identify appropriate predictors using comprehensive data analysis methods. • New findings: We used a random forest algorithm and a logistic regression-based nomogram to identify significant predictors of pneumonia among ARI patients. Elevated D-dimer levels and influenza A virus infection were found to be significantly associated with an increased risk of pneumonia. Other important indicators identified included age, neutrophils, lymphocytes, total protein, globulin, triglycerides, total bilirubin, and procalcitonin. • Significance of the study: The findings provide a basis for identifying high-risk ARI patients who may progress to pneumonia. The identified predictors can be used to develop clinical prediction models to guide early diagnosis and intervention, potentially improving patient outcomes and optimizing the use of medical resources.